Predicted to enable ATPase binding activity. Involved in negative regulation of ERAD pathway; negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly; and negative regulation of ubiquitin-dependent protein catabolic process. Predicted to be located in membrane. Predicted to be active in endoplasmic reticulum membrane. Orthologous to human SVIP (small VCP interacting protein).
RGD Description
Predicted to enable ATPase binding activity. Involved in negative regulation of ERAD pathway; negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly; and negative regulation of ubiquitin-dependent protein catabolic process. Predicted to be located in membrane. Predicted to be active in endoplasmic reticulum membrane. Orthologous to human SVIP (small VCP interacting protein); INTERACTS WITH 2,3,7,8-Tetrachlorodibenzofuran; 4,4'-sulfonyldiphenol; 6-propyl-2-thiouracil.